Phathom cuts commercial chief, pares down DTC promotion in cost-saving drive
After seeing its spending soar and net loss grow to over $90 million in the first quarter, Phathom Pharmaceuticals is making cost-cutting moves—including significant changes to its marketing department.
After seeing its spending soar and net loss grow to over $90 million in the first quarter, Phathom Pharmaceuticals is making cost-cutting moves—including significant changes to its marketing department.
